IoT hiring levels in the pharmaceutical industry rose in May 2022

Farma Darya

The proportion of pharmaceutical companies hiring for IoT related positions rose in May 2022 compared with the equivalent month last year, with 18.3% of the companies included in our analysis recruiting for at least one such position.

This latest figure was higher than the 16% of companies who were hiring for IoT related jobs a year ago and an increase compared to the figure of 17.3% in April 2022.

When it came to the rate of all job openings that were linked to IoT, related job postings kept steady in May 2022 from April 2022, with 0.4% of newly posted job advertisements being linked to the topic.

This latest figure was the highest monthly figure recorded in the past year and is an increase compared to the 0.3% of newly advertised jobs that were linked to IoT in the equivalent month a year ago.

IoT is one of the topics that GlobalData, from whom our data for this article is taken, have identified as being a key disruptive force facing companies in the coming years. Companies that excel and invest in these areas now are thought to be better prepared for the future business landscape and better equipped to survive unforeseen challenges.

Our analysis of the data shows that pharmaceutical companies are currently hiring for IoT jobs at a rate lower than the average for all companies within GlobalData’s job analytics database. The average among all companies stood at 0.9% in May 2022.

GlobalData’s job analytics database tracks the daily hiring patterns of thousands of companies across the world, drawing in jobs as they’re posted and tagging them with additional layers of data on everything from the seniority of each position to whether a job is linked to wider industry trends.

Related Companies

Next Post

Israeli innovation lab backed by pharmaceutical, biotech giants mints 1st AI startup

An Israeli biotechnology innovation lab set up last year and backed by some of the world’s leading pharmaceutical companies like Pfizer and Merck has formed a new startup that will harness artificial intelligence (AI) to assess drug efficacy in pre-clinical trials and improve chances for success in later stages. The […]